Nom du produit:5-Bromo-3-cyclopropyl-1H-pyrazolo[3,4-b]pyridine
IUPAC Name:5-bromo-3-cyclopropyl-1H-pyrazolo[3,4-b]pyridine
- CAS：1211537-03-9
- Formule moléculaire：C9H8BrN3
- Pureté：95%
- Numéro de catalogue：CM152063
- Poids moléculaire：238.09
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:1211537-03-9
- Formule moléculaire:C9H8BrN3
- Point de fusion:-
- Code SMILES:BrC1=CN=C(NN=C2C3CC3)C2=C1
- Densité:
- Numéro de catalogue:CM152063
- Poids moléculaire:238.09
- Point d'ébullition:
- N° Mdl:MFCD18260550
- Stockage:
Category Infos
- Pyrazolopyridines
- Over the past few years, many pyrazole fused-ring systems, especially with applications in medicinal chemistry, have been published. These include general structures such as pyrazoline, pyrazoline, pyrazoquinoline, pyrazoloisoquinoline, pyrazoline, pyrazolopyrazine, pyrazolopyrazine, pyranopyrazole, pyrano Pyrazoles, pyrazolotriazines and pyrazole fused phosphorus rings.
- Cyclopropanes
- Cyclopropane is the smallest cyclic compound with unique structural features and physicochemical properties, which is widely used in the design of small molecule drugs. In drug design, it is often used to increase activity, fix conformation and improve PK and water solubility. The introduction of cyclopropyl groups into drugs can change various properties of molecules, such as improving metabolic stability; increasing biological activity; enhancing drug efficacy; limiting polypeptide conformation and slowing down its hydrolysis; reducing plasma clearance; improving drug dissociation and many more. Cyclopropane rings are widely found in marketed drugs, including cardiovascular drugs, central nervous system (CNS) drugs, anticancer drugs, autoimmune and anti-inflammatory drugs.
Recherche 
+86 21 5895 0110 
